Found: 62
Select item for more details and to access through your institution.
L3MBTL2 maintains MYCN‐amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes.
- Published in:
- Genes to Cells, 2024, v. 29, n. 10, p. 838, doi. 10.1111/gtc.13148
- By:
- Publication type:
- Article
Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency.
- Published in:
- Human Genetics, 2001, v. 109, n. 5, p. 526, doi. 10.1007/s004390100603
- By:
- Publication type:
- Article
Identification of Genes Targeted by CpG Island Methylator Phenotype in Neuroblastomas, and Their Possible Integrative Involvement in Poor Prognosis.
- Published in:
- Oncology, 2008, v. 74, n. 1/2, p. 50, doi. 10.1159/000139124
- By:
- Publication type:
- Article
ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03450
- By:
- Publication type:
- Article
Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 1, p. 18, doi. 10.3390/biom12010018
- By:
- Publication type:
- Article
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
- Published in:
- Oncogene, 2004, v. 23, n. 35, p. 5901, doi. 10.1038/sj.onc.1207782
- By:
- Publication type:
- Article
Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets.
- Published in:
- Oncogene, 2003, v. 22, n. 35, p. 5525, doi. 10.1038/sj.onc.1206853
- By:
- Publication type:
- Article
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14338-5
- By:
- Publication type:
- Article
Robust Model Selection for Classification of Microarrays.
- Published in:
- Cancer Informatics, 2009, n. 7, p. 141, doi. 10.4137/CIN.S2704
- By:
- Publication type:
- Article
The Genomic Analysis of Human DAN Gene.
- Published in:
- DNA & Cell Biology, 1997, v. 16, n. 9, p. 1031, doi. 10.1089/dna.1997.16.1031
- By:
- Publication type:
- Article
Comparative epigenomics by machine learning approach for neuroblastoma.
- Published in:
- BMC Genomics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12864-022-09061-y
- By:
- Publication type:
- Article
Comparative epigenomics by machine learning approach for neuroblastoma.
- Published in:
- BMC Genomics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12864-022-09061-y
- By:
- Publication type:
- Article
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10772-y
- By:
- Publication type:
- Article
<i>NCYM</i>, a <i>Cis</i>-Antisense Gene of <i>MYCN</i>, Encodes a <i>De Novo</i> Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 1, p. 1, doi. 10.1371/journal.pgen.1003996
- By:
- Publication type:
- Article
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma.
- Published in:
- Oncogenesis, 2021, v. 10, n. 11, p. 1, doi. 10.1038/s41389-021-00363-6
- By:
- Publication type:
- Article
Isolation and chromosomal assignment of human genes encoding cofactor of LIM homeodomain proteins, CLIM1 and CLIM2.
- Published in:
- Journal of Human Genetics, 1999, v. 44, n. 2, p. 112, doi. 10.1007/s100380050120
- By:
- Publication type:
- Article
Chromosomal assignment of a human apoptosis-associated tyrosine kinase gene on chromosome 17q25.3 by somatic hybrid analysis and fluorescence in situ hybridization.
- Published in:
- Journal of Human Genetics, 1999, v. 44, n. 2, p. 141, doi. 10.1007/s100380050130
- By:
- Publication type:
- Article
Isolation, tissue expression, and chromosomal assignment of human RGS5, a novel G-protein signaling regulator gene.
- Published in:
- Journal of Human Genetics, 1998, v. 43, n. 3, p. 202, doi. 10.1007/s100380050071
- By:
- Publication type:
- Article
Assignment of the ZIP kinase gene to human chromosome 19p13.3 by somatic hybrid analysis and fluorescence in-situ hybridization.
- Published in:
- Journal of Human Genetics, 1998, v. 43, n. 3, p. 209, doi. 10.1007/s100380050073
- By:
- Publication type:
- Article
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.
- Published in:
- Oncology Reports, 2021, v. 46, n. 1, p. N.PAG, doi. 10.3892/or.2021.8086
- By:
- Publication type:
- Article
p73, a geme related to p53, is not mutated in esophageal carcinomas.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 4, p. 437, doi. 10.1002/(SICI)1097-0215(19981109)78:4<437::AID-IJC8>3.0.CO;2-V
- By:
- Publication type:
- Article
Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019297
- By:
- Publication type:
- Article
A nationwide phase II study of delayed local treatment for children with high‐risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN‐H‐11.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 6, p. 1, doi. 10.1002/pbc.30976
- By:
- Publication type:
- Article
Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas
- Published in:
- Genes, Chromosomes & Cancer, 2003, v. 36, n. 2, p. 139, doi. 10.1002/gcc.10151
- By:
- Publication type:
- Article
Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors.
- Published in:
- Genes, Chromosomes & Cancer, 2002, v. 35, n. 2, p. 170, doi. 10.1002/gcc.10080
- By:
- Publication type:
- Article
Stronger Prognostic Power of the CpG Island Methylator Phenotype than Methylation of Individual Genes in Neuroblastomas.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 641, doi. 10.1093/jjco/hyt058
- By:
- Publication type:
- Article
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells.
- Published in:
- Cancer Science, 2023, v. 114, n. 5, p. 1898, doi. 10.1111/cas.15730
- By:
- Publication type:
- Article
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4193, doi. 10.1111/cas.15555
- By:
- Publication type:
- Article
FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 587, doi. 10.1111/cas.15205
- By:
- Publication type:
- Article
Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1351, doi. 10.1111/cas.12746
- By:
- Publication type:
- Article
Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
- Published in:
- Cancer Science, 2015, v. 106, n. 7, p. 840, doi. 10.1111/cas.12677
- By:
- Publication type:
- Article
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma.
- Published in:
- Cancer Science, 2015, v. 106, n. 6, p. 766, doi. 10.1111/cas.12665
- By:
- Publication type:
- Article
Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.
- Published in:
- Cancer Science, 2015, v. 106, n. 4, p. 421, doi. 10.1111/cas.12610
- By:
- Publication type:
- Article
Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma.
- Published in:
- Cancer Science, 2013, v. 104, n. 5, p. 563, doi. 10.1111/cas.12115
- By:
- Publication type:
- Article
Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
- Published in:
- Cancer Science, 2010, v. 101, n. 11, p. 2295, doi. 10.1111/j.1349-7006.2010.01681.x
- By:
- Publication type:
- Article
Plasma midkine level is a prognostic factor for human neuroblastoma.
- Published in:
- Cancer Science, 2008, v. 99, n. 10, p. 2070, doi. 10.1111/j.1349-7006.2008.00957.x
- By:
- Publication type:
- Article
PPP3CB contributes to poor prognosis through activating nuclear factor of activated T‐cells signaling in neuroblastoma.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 3, p. 426, doi. 10.1002/mc.22939
- By:
- Publication type:
- Article
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice.
- Published in:
- Oncogene, 2001, v. 20, n. 56, p. 8100, doi. 10.1038/sj.onc.1204987
- By:
- Publication type:
- Article
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
- Published in:
- Oncogene, 2000, v. 19, n. 37, p. 4302, doi. 10.1038/sj.onc.1203786
- By:
- Publication type:
- Article
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
- Published in:
- Oncogene, 2000, v. 19, n. 5, p. 617, doi. 10.1038/sj.onc.1203358
- By:
- Publication type:
- Article
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
- Published in:
- Oncogene, 1999, v. 18, n. 4, p. 1061, doi. 10.1038/sj.onc.1202390
- By:
- Publication type:
- Article
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 5, p. 965, doi. 10.1007/s10147-018-1281-8
- By:
- Publication type:
- Article
Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 3, p. 185, doi. 10.1007/s00432-006-0156-y
- By:
- Publication type:
- Article
Oncogenic mutations of ALK kinase in neuroblastoma.
- Published in:
- Nature, 2008, v. 455, n. 7215, p. 971, doi. 10.1038/nature07399
- By:
- Publication type:
- Article
Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 9, p. 2087, doi. 10.1002/ijc.23776
- By:
- Publication type:
- Article
The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 5, p. 1117, doi. 10.1002/ijc.23613
- By:
- Publication type:
- Article
Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 3, p. 365, doi. 10.1002/ijc.20431
- By:
- Publication type:
- Article